A Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay

NCT02395575 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Sponsor

NanoString Technologies, Inc.

Collaborators

[object Object]